SGLT2 inhibition mitigates transition from acute kidney injury to chronic kidney disease by suppressing ferroptosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
SGLT2 inhibition mitigates transition from acute kidney injury to chronic kidney disease by suppressing ferroptosis ; volume:14 ; number:1 ; day:2 ; month:9 ; year:2024 ; pages:1-17 ; date:12.2024
Scientific reports ; 14, Heft 1 (2.9.2024), 1-17, 12.2024
- Creator
-
Hirashima, Yutaro
Nakano, Toshiaki
Torisu, Kumiko
Aihara, Seishi
Wakisaka, Masanori
Kitazono, Takanari
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-71416-0
- URN
-
urn:nbn:de:101:1-2411180007479.547562125886
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hirashima, Yutaro
- Nakano, Toshiaki
- Torisu, Kumiko
- Aihara, Seishi
- Wakisaka, Masanori
- Kitazono, Takanari
- SpringerLink (Online service)
Other Objects (12)
Targeting ferroptosis for treating kidney disease
Role of ferroptosis in chronic kidney disease
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
Ferroptosis and its emerging role in kidney stone formation
Capsaicin mitigates ventilator-induced lung injury by suppressing ferroptosis and maintaining mitochondrial redox homeostasis through SIRT3-dependent mechanisms
SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis
Seratrodast inhibits ferroptosis by suppressing lipid peroxidation
Targeting ferroptosis for treating kidney disease
Role of ferroptosis in chronic kidney disease
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
Ferroptosis and its emerging role in kidney stone formation
Capsaicin mitigates ventilator-induced lung injury by suppressing ferroptosis and maintaining mitochondrial redox homeostasis through SIRT3-dependent mechanisms
SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis
Seratrodast inhibits ferroptosis by suppressing lipid peroxidation
Targeting ferroptosis for treating kidney disease
Role of ferroptosis in chronic kidney disease
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?
SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease
Ferroptosis and its emerging role in kidney stone formation
Capsaicin mitigates ventilator-induced lung injury by suppressing ferroptosis and maintaining mitochondrial redox homeostasis through SIRT3-dependent mechanisms
SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis